<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Does Your Dyspneic Patient Have CHF?</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->8/24/2012</div></div><div class="card__content"><h1 id="does-a-dyspneic-patient-have-congestive-heart-failure-chf-">Does a Dyspneic Patient Have Congestive Heart Failure (CHF)?</h1>
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12615582">McCullough et al: ED patients WITH a history of asthma or COPD</a></p>
<h2 id="population-emergency-department-patients">Population: Emergency Department patients</h2>
<table>
<thead>
<tr>
<th>Finding</th>
<th align="right">(+) LR</th>
<th align="right">(-) LR</th>
</tr>
</thead>
<tbody><tr>
<td>Initial clinical judgment</td>
<td align="right"><strong>4.4</strong> (1.8-10)</td>
<td align="right">0.45 (0.28-0.73)</td>
</tr>
<tr>
<td><strong>HISTORY</strong></td>
<td align="right">|</td>
<td align="right"></td>
</tr>
<tr>
<td>• Heart failure</td>
<td align="right"><strong>5.8</strong> (4.1-8.0)</td>
<td align="right">0.45 (0.38-0.53)</td>
</tr>
<tr>
<td>• Myocardial infarctio</td>
<td align="right"><strong>3.1</strong> (1.3-5.8)</td>
<td align="right">0.69 (0.58-0.82)</td>
</tr>
<tr>
<td>• Coronary artery disease</td>
<td align="right">1.8 (1.1-2.8)</td>
<td align="right">0.68 (0.48-0.96)</td>
</tr>
<tr>
<td>• Dyslipidemia</td>
<td align="right">1.7 (0.43-6.9)</td>
<td align="right">0.89 (0.69-1.1)</td>
</tr>
<tr>
<td>• Diabetes mellitus</td>
<td align="right">1.7 (1.0-2.7)</td>
<td align="right">0.86 (0.73-1.0)</td>
</tr>
<tr>
<td>• Hypertension</td>
<td align="right">1.4 (1.1-1.7)</td>
<td align="right">0.71 (0.55-0.93)</td>
</tr>
<tr>
<td>• Smoking</td>
<td align="right">0.84 (0.58-1.2)</td>
<td align="right">1.4 (0.58-3.6)</td>
</tr>
<tr>
<td>• COPD</td>
<td align="right">0.81 (0.60-1.1)</td>
<td align="right">1.1 (0.95-1.4)</td>
</tr>
<tr>
<td><strong>SYMPTOMS</strong></td>
<td align="right">|</td>
<td align="right"></td>
</tr>
<tr>
<td>• Paroxysmal noctural dyspnea</td>
<td align="right">2.6 (1.5-4.5)</td>
<td align="right">0.70 (0.54-0.91)</td>
</tr>
<tr>
<td>• Orthopnea</td>
<td align="right">2.2 (1.2-3.9)</td>
<td align="right">0.65 (0.45-0.92)</td>
</tr>
<tr>
<td>• Edema</td>
<td align="right">2.1 (0.92-5.0)</td>
<td align="right">0.64 (0.39-1.1)</td>
</tr>
<tr>
<td>• Dyspnea on exertion</td>
<td align="right">1.3 (1.2-1.4)</td>
<td align="right">0.48 (0.35-0.67)</td>
</tr>
<tr>
<td>• Fatigue and weight gain</td>
<td align="right">1.0 (0.74-1.4)</td>
<td align="right">0.99 (0.85-1.1)</td>
</tr>
<tr>
<td>• Cough</td>
<td align="right">0.93 (0.70-1.2)</td>
<td align="right">1.0 (0.87-1.3)</td>
</tr>
<tr>
<td><strong>PHYSICAL EXAM</strong></td>
<td align="right">|</td>
<td align="right"></td>
</tr>
<tr>
<td>• S3 (ventricular filling gallop)</td>
<td align="right"><strong>11</strong> (4.9-25.0)</td>
<td align="right">0.88 (0.83-0.94)</td>
</tr>
<tr>
<td>• Abdominal jugular reflex</td>
<td align="right"><strong>6.4</strong> (0.81-51.0)</td>
<td align="right">0.79 (0.62-1.0)</td>
</tr>
<tr>
<td>• Jugular venous distension</td>
<td align="right"><strong>5.1</strong> (3.2-7.9)</td>
<td align="right">0.66 (0.57-0.77)</td>
</tr>
<tr>
<td>• Rales</td>
<td align="right">2.8 (1.9-4.1)</td>
<td align="right">0.51 (0.37-0.70)</td>
</tr>
<tr>
<td>• Any murmur</td>
<td align="right">2.6 (1.7-4.1)</td>
<td align="right">0.81 (0.73--0.90)</td>
</tr>
<tr>
<td>• Lower extremity edema</td>
<td align="right">2.3 (1.5-3.7)</td>
<td align="right">0.64 (0.47-0.87)</td>
</tr>
<tr>
<td>• Valsalva maneuver</td>
<td align="right">2.1 (1.0-4.2)</td>
<td align="right">0.41 (0.17-1.0)</td>
</tr>
<tr>
<td>• SBP &lt;100 mmHg</td>
<td align="right">2.0 (0.60-6.6)</td>
<td align="right">0.97 (0.91-1.0)</td>
</tr>
<tr>
<td>• S4 (atrial gallop)</td>
<td align="right">1.6 (0.47-5.5)</td>
<td align="right">0.98 (0.93-1.0)</td>
</tr>
<tr>
<td>• SBP &ge;150 mmHg</td>
<td align="right">1.0 (0.69-1.6)</td>
<td align="right">0.99 (0.84-1.2)</td>
</tr>
<tr>
<td>• Wheezing</td>
<td align="right">0.52 (0.38-0.71)</td>
<td align="right">1.3 (1.1-1.7)</td>
</tr>
<tr>
<td>• Ascites</td>
<td align="right">0.33 (0.04-2.9)</td>
<td align="right">1.0 (0.99-1.1)</td>
</tr>
<tr>
<td><strong>CHEST RADIOGRAPH</strong></td>
<td align="right">|</td>
<td align="right"></td>
</tr>
<tr>
<td>• Pulmonary venous congestion</td>
<td align="right"><strong>12.0</strong> (6.8-21.0)</td>
<td align="right">0.48 (0.28-0.83)</td>
</tr>
<tr>
<td>• Interstitial edema</td>
<td align="right"><strong>12.0</strong> (5.2-27.0)</td>
<td align="right">0.68 (0.54-0.85)</td>
</tr>
<tr>
<td>• Alveolar edema</td>
<td align="right"><strong>6.0</strong> (2.2-16.0)</td>
<td align="right">0.95 (0.93-0.97)</td>
</tr>
<tr>
<td>• Cardiomegaly</td>
<td align="right"><strong>3.3</strong> (2.4-4.7)</td>
<td align="right">0.33 (0.23-0.48)</td>
</tr>
<tr>
<td>• Pleural effusion</td>
<td align="right"><strong>3.2</strong> (2.4-4.3)</td>
<td align="right">0.81 (0.77-0.85)</td>
</tr>
<tr>
<td>• Any edema</td>
<td align="right"><strong>3.1</strong> (0.60-16.0)</td>
<td align="right">0.38 (0.11-1.3)</td>
</tr>
<tr>
<td>• Pneumonia</td>
<td align="right">0.50 (0.29-0.87)</td>
<td align="right">1.0 (1.0-1.1)</td>
</tr>
<tr>
<td>• Hyperinflation</td>
<td align="right">0.38 (0.20-0.69)</td>
<td align="right">1.1 (1.0-1.1)</td>
</tr>
<tr>
<td><strong>ECG</strong></td>
<td align="right">|</td>
<td align="right"></td>
</tr>
<tr>
<td>• Atrial fibrillation</td>
<td align="right"><strong>3.8</strong> (1.7-8.8)</td>
<td align="right">0.79 (0.66-0.96)</td>
</tr>
<tr>
<td>• New T-wave changes</td>
<td align="right"><strong>3.0</strong> (1.7-5.3)</td>
<td align="right">0.83 (0.74-0.93)</td>
</tr>
<tr>
<td>• Any abnormal finding</td>
<td align="right"><strong>2.2</strong> (1.6-3.1)</td>
<td align="right">0.64 (0.47-0.88)</td>
</tr>
<tr>
<td>• ST elevation</td>
<td align="right">1.8 (0.80-4.0)</td>
<td align="right">0.98 (0.94-1.0)</td>
</tr>
<tr>
<td>• ST depression</td>
<td align="right">1.7 (0.97-2.9)</td>
<td align="right">0.95 (0.90-1.0)</td>
</tr>
</tbody></table>
<p>(NS = not significant because LR crosses 1.0)</p>
<h2 id="subset-population-ed-patient-with-a-history-of-asthma-or-copd">Subset population: ED patient WITH a history of asthma or COPD</h2>
<table>
<thead>
<tr>
<th>Finding</th>
<th align="right">(+) LR</th>
<th align="right">(-) LR</th>
</tr>
</thead>
<tbody><tr>
<td>Initial clinical judgment</td>
<td align="right"><strong>9.5</strong> (5.3-18)</td>
<td align="right">0.65 (0.55-0.77)</td>
</tr>
<tr>
<td><strong>HISTORY</strong></td>
<td align="right">|</td>
<td align="right"></td>
</tr>
<tr>
<td>• Atrial fibrillation</td>
<td align="right"><strong>4.1</strong> (2.5-6.6)</td>
<td align="right">0.74 (0.63-0.85</td>
</tr>
<tr>
<td>• CABG</td>
<td align="right">2.8 (1.3-5.8)</td>
<td align="right">0.92 (0.84-0.99)</td>
</tr>
<tr>
<td>• Diabetes mellitus</td>
<td align="right">2.0 (1.3-3.2)</td>
<td align="right">0.85 (0.74-0.97)</td>
</tr>
<tr>
<td>• Coronary artery disease</td>
<td align="right">2.0 (1.5-2.6)</td>
<td align="right">0.67 (0.54-0.84)</td>
</tr>
<tr>
<td>• Hypertension</td>
<td align="right">NS</td>
<td align="right">NS</td>
</tr>
<tr>
<td><strong>SYMPTOMS</strong></td>
<td align="right">|</td>
<td align="right"></td>
</tr>
<tr>
<td>• Orthopnea</td>
<td align="right">1.3 (1.1-1.5)</td>
<td align="right">0.68 (0.48-0.95)</td>
</tr>
<tr>
<td>• Noctural cough</td>
<td align="right">NS</td>
<td align="right">NS</td>
</tr>
<tr>
<td><strong>PHYSICAL EXAM</strong></td>
<td align="right">|</td>
<td align="right"></td>
</tr>
<tr>
<td>• S3 (ventricular filling gallup)</td>
<td align="right"><strong>57.0</strong> (7.6-425)</td>
<td align="right">0.83 (0.75-0.91)</td>
</tr>
<tr>
<td>• Jugular venous distension</td>
<td align="right"><strong>4.3</strong> (2.8-6.5)</td>
<td align="right">0.65 (0.54-0.78)</td>
</tr>
<tr>
<td>• Leg edema</td>
<td align="right">2.7 (2.2-3.5) 0.41 (0.30-0.57)</td>
<td align="right"></td>
</tr>
<tr>
<td>• Rales</td>
<td align="right">2.6 (1.2-4.7)</td>
<td align="right">0.39 (0.28-0.55)</td>
</tr>
<tr>
<td>• Hepatic congestion</td>
<td align="right">2.4 (1.2-4.7)</td>
<td align="right">0.91 (0.84-1.0)</td>
</tr>
<tr>
<td>• Cardiomegaly</td>
<td align="right">NS</td>
<td align="right">NS</td>
</tr>
<tr>
<td>• Wheezing</td>
<td align="right">NS</td>
<td align="right">NS</td>
</tr>
<tr>
<td><strong>ECG</strong></td>
<td align="right">|</td>
<td align="right"></td>
</tr>
<tr>
<td>• Atrial fibrillation</td>
<td align="right"><strong>6.0</strong> (3.4-10.0)</td>
<td align="right">0.74 (0.63-0.84)</td>
</tr>
<tr>
<td>• Ischemic ST-T waves</td>
<td align="right"><strong>4.6</strong> (2.4-8.7)</td>
<td align="right">0.83 (0.74-0.93)</td>
</tr>
<tr>
<td>• Q waves</td>
<td align="right"><strong>3.1</strong> (1.8-5.5)</td>
<td align="right">0.84 (0.75-0.94)</td>
</tr>
<tr>
<td>Serum BNP &ge;100 pg/mL</td>
<td align="right"><strong>4.1</strong> (3.5-5.0)</td>
<td align="right"><strong>0.09</strong> (0.04-0.19)</td>
</tr>
</tbody></table>
<h2 id="bnp-test-characteristics-to-predict-chf-in-ed-patients-asthma-or-copd">BNP test characteristics to predict CHF in ED patients +/- asthma or COPD</h2>
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16234501">Wang et al. (2005)</a></p>
<table>
<thead>
<tr>
<th align="right">BNP level (pg/mL)</th>
<th align="right">(+) LR</th>
<th align="right">(-) LR</th>
</tr>
</thead>
<tbody><tr>
<td align="right">&ge; 250</td>
<td align="right">4.6 (2.6-8.0)</td>
<td align="right">0.14 (0.06-0.33)</td>
</tr>
<tr>
<td align="right">&ge; 200</td>
<td align="right">3.7 (2.6-5.4)</td>
<td align="right">0.11 (0.07-0.18)</td>
</tr>
<tr>
<td align="right">&ge; 150</td>
<td align="right">3.1 (2.1-4.5)</td>
<td align="right">0.15 (0.11-0.21)</td>
</tr>
<tr>
<td align="right">&ge; 100</td>
<td align="right">2.7 (2.0-3.9)</td>
<td align="right">0.11 (0.07-0.16)</td>
</tr>
<tr>
<td align="right">&ge; 80</td>
<td align="right">3.3 (1.8-6.3)</td>
<td align="right">0.06 (0.03-0.13)</td>
</tr>
<tr>
<td align="right">&ge; 50</td>
<td align="right">1.7 (1.2-2.6)</td>
<td align="right">0.06 (0.03-0.12)</td>
</tr>
</tbody></table>
<h2 id="references">References</h2>
<ul>
<li>McCullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T, McCord J, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS; BNP Multinational Study Investigators. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med. 2003 Mar;10(3):198-204. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12615582">PubMed</a>]</li>
<li>Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005 Oct 19;294(15):1944-56. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16234501">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"does-your-pt-have-chf","title":"Does Your Dyspneic Patient Have CHF?","authors":["Michelle Lin, MD"],"categories":[{"slug":"cardiovascular","name":"Cardiovascular"},{"slug":"ebm","name":"EBM"}],"created":"2012/08/24","updated":null,"body":"\n# Does a Dyspneic Patient Have Congestive Heart Failure (CHF)?\n\n[McCullough et al: ED patients WITH a history of asthma or COPD](https://www.ncbi.nlm.nih.gov/pubmed/?term=12615582)\n\n## Population: Emergency Department patients\n\n| Finding                              |              (+) LR |            (-) LR |\n| ------------------------------------ | ------------------: | ----------------: |\n| Initial clinical judgment            |    **4.4** (1.8-10) |  0.45 (0.28-0.73) |\n| **HISTORY**                          |                     |                   |\n| • Heart failure                      |   **5.8** (4.1-8.0) |  0.45 (0.38-0.53) |\n| • Myocardial infarctio               |   **3.1** (1.3-5.8) |  0.69 (0.58-0.82) |\n| • Coronary artery disease            |       1.8 (1.1-2.8) |  0.68 (0.48-0.96) |\n| • Dyslipidemia                       |      1.7 (0.43-6.9) |   0.89 (0.69-1.1) |\n| • Diabetes mellitus                  |       1.7 (1.0-2.7) |   0.86 (0.73-1.0) |\n| • Hypertension                       |       1.4 (1.1-1.7) |  0.71 (0.55-0.93) |\n| • Smoking                            |     0.84 (0.58-1.2) |    1.4 (0.58-3.6) |\n| • COPD                               |     0.81 (0.60-1.1) |    1.1 (0.95-1.4) |\n| **SYMPTOMS**                         |                     |                   |\n| • Paroxysmal noctural dyspnea        |       2.6 (1.5-4.5) |  0.70 (0.54-0.91) |\n| • Orthopnea                          |       2.2 (1.2-3.9) |  0.65 (0.45-0.92) |\n| • Edema                              |      2.1 (0.92-5.0) |   0.64 (0.39-1.1) |\n| • Dyspnea on exertion                |       1.3 (1.2-1.4) |  0.48 (0.35-0.67) |\n| • Fatigue and weight gain            |      1.0 (0.74-1.4) |   0.99 (0.85-1.1) |\n| • Cough                              |     0.93 (0.70-1.2) |    1.0 (0.87-1.3) |\n| **PHYSICAL EXAM**                    |                     |                   |\n| • S3 (ventricular filling gallop)    |   **11** (4.9-25.0) |  0.88 (0.83-0.94) |\n| • Abdominal jugular reflex           | **6.4** (0.81-51.0) |   0.79 (0.62-1.0) |\n| • Jugular venous distension          |   **5.1** (3.2-7.9) |  0.66 (0.57-0.77) |\n| • Rales                              |       2.8 (1.9-4.1) |  0.51 (0.37-0.70) |\n| • Any murmur                         |       2.6 (1.7-4.1) | 0.81 (0.73--0.90) |\n| • Lower extremity edema              |       2.3 (1.5-3.7) |  0.64 (0.47-0.87) |\n| • Valsalva maneuver                  |       2.1 (1.0-4.2) |   0.41 (0.17-1.0) |\n| • SBP \u0026lt;100 mmHg                   |      2.0 (0.60-6.6) |   0.97 (0.91-1.0) |\n| • S4 (atrial gallop)                 |      1.6 (0.47-5.5) |   0.98 (0.93-1.0) |\n| • SBP \u0026ge;150 mmHg                   |      1.0 (0.69-1.6) |   0.99 (0.84-1.2) |\n| • Wheezing                           |    0.52 (0.38-0.71) |     1.3 (1.1-1.7) |\n| • Ascites                            |     0.33 (0.04-2.9) |    1.0 (0.99-1.1) |\n| **CHEST RADIOGRAPH**                 |                     |                   |\n| • Pulmonary venous congestion        | **12.0** (6.8-21.0) |  0.48 (0.28-0.83) |\n| • Interstitial edema                 | **12.0** (5.2-27.0) |  0.68 (0.54-0.85) |\n| • Alveolar edema                     |  **6.0** (2.2-16.0) |  0.95 (0.93-0.97) |\n| • Cardiomegaly                       |   **3.3** (2.4-4.7) |  0.33 (0.23-0.48) |\n| • Pleural effusion                   |   **3.2** (2.4-4.3) |  0.81 (0.77-0.85) |\n| • Any edema                          | **3.1** (0.60-16.0) |   0.38 (0.11-1.3) |\n| • Pneumonia                          |    0.50 (0.29-0.87) |     1.0 (1.0-1.1) |\n| • Hyperinflation                     |    0.38 (0.20-0.69) |     1.1 (1.0-1.1) |\n| **ECG**                              |                     |                   |\n| • Atrial fibrillation                |   **3.8** (1.7-8.8) |  0.79 (0.66-0.96) |\n| • New T-wave changes                 |   **3.0** (1.7-5.3) |  0.83 (0.74-0.93) |\n| • Any abnormal finding               |   **2.2** (1.6-3.1) |  0.64 (0.47-0.88) |\n| • ST elevation                       |      1.8 (0.80-4.0) |   0.98 (0.94-1.0) |\n| • ST depression                      |      1.7 (0.97-2.9) |   0.95 (0.90-1.0) |\n\n(NS = not significant because LR crosses 1.0)\n\n## Subset population: ED patient WITH a history of asthma or COPD\n\n| Finding                              |                         (+) LR |               (-) LR |\n| ------------------------------------ | -----------------------------: | -------------------: |\n| Initial clinical judgment            |               **9.5** (5.3-18) |     0.65 (0.55-0.77) |\n| **HISTORY**                          |                                |                      |\n| • Atrial fibrillation                |              **4.1** (2.5-6.6) |      0.74 (0.63-0.85 |\n| • CABG                               |                  2.8 (1.3-5.8) |     0.92 (0.84-0.99) |\n| • Diabetes mellitus                  |                  2.0 (1.3-3.2) |     0.85 (0.74-0.97) |\n| • Coronary artery disease            |                  2.0 (1.5-2.6) |     0.67 (0.54-0.84) |\n| • Hypertension                       |                             NS |                   NS |\n| **SYMPTOMS**                         |                                |                      |\n| • Orthopnea                          |                  1.3 (1.1-1.5) |     0.68 (0.48-0.95) |\n| • Noctural cough                     |                             NS |                   NS |\n| **PHYSICAL EXAM**                    |                                |                      |\n| • S3 (ventricular filling gallup)    |             **57.0** (7.6-425) |     0.83 (0.75-0.91) |\n| • Jugular venous distension          |              **4.3** (2.8-6.5) |     0.65 (0.54-0.78) |\n| • Leg edema                          | 2.7 (2.2-3.5) 0.41 (0.30-0.57) |                      |\n| • Rales                              |                  2.6 (1.2-4.7) |     0.39 (0.28-0.55) |\n| • Hepatic congestion                 |                  2.4 (1.2-4.7) |      0.91 (0.84-1.0) |\n| • Cardiomegaly                       |                             NS |                   NS |\n| • Wheezing                           |                             NS |                   NS |\n| **ECG**                              |                                |                      |\n| • Atrial fibrillation                |             **6.0** (3.4-10.0) |     0.74 (0.63-0.84) |\n| • Ischemic ST-T waves                |              **4.6** (2.4-8.7) |     0.83 (0.74-0.93) |\n| • Q waves                            |              **3.1** (1.8-5.5) |     0.84 (0.75-0.94) |\n| Serum BNP \u0026ge;100 pg/mL              |              **4.1** (3.5-5.0) | **0.09** (0.04-0.19) |\n\n## BNP test characteristics to predict CHF in ED patients +/- asthma or COPD \n\n[Wang et al. (2005)](https://www.ncbi.nlm.nih.gov/pubmed/?term=16234501)\n\n| BNP level (pg/mL)     |        (+) LR |           (-) LR |\n| --------------------: | ------------: | ---------------: |\n|              \u0026ge; 250 | 4.6 (2.6-8.0) | 0.14 (0.06-0.33) |\n|              \u0026ge; 200 | 3.7 (2.6-5.4) | 0.11 (0.07-0.18) |\n|              \u0026ge; 150 | 3.1 (2.1-4.5) | 0.15 (0.11-0.21) |\n|              \u0026ge; 100 | 2.7 (2.0-3.9) | 0.11 (0.07-0.16) |\n|               \u0026ge; 80 | 3.3 (1.8-6.3) | 0.06 (0.03-0.13) |\n|               \u0026ge; 50 | 1.7 (1.2-2.6) | 0.06 (0.03-0.12) |\n\n## References\n\n- McCullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T, McCord J, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS; BNP Multinational Study Investigators. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med. 2003 Mar;10(3):198-204. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=12615582)]\n- Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005 Oct 19;294(15):1944-56. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=16234501)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"does-your-pt-have-chf"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>